Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and Associated Risk Actors Among Pulmonary Presumptive TB Patients in Eastern Amhara, Ethiopia: 2015–2019 | SpringerLink
Mycobacterium tuberculosis clinical isolates carry mutational signatures of host immune environments | Science Advances
MRIGlobal - As a partner in the Mycobacterium tuberculosis (Mtb) Quality Assessment Program (TBQA), we evaluate technologies, support research, and study trends that support improved response and treatment. Read more in our
Frontiers | Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review
The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study | Scientific Reports
Integration of TB-LAM and Xpert MTB/RIF (Xpert) testing to improve TB case detection and shorten time to treatment initiation among People Living with HIV (PLHIV) in Harare City, Zimbabwe
Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in Yangon Regional Tuberculosis Center, Myanmar: a cross-sectional study | BMC Health Services Research | Full Text
TropicalMed | Free Full-Text | Missing Cases of Bacteriologically Confirmed TB/DR-TB from the National Treatment Registers in West and North Sumatra Provinces, Indonesia
Comprehensive gene profiling, molecular tumor board (mtb) and artificial intelligence in the diagnosis and treatment of patients with rare adult cancers – EJP RD – European Joint Programme on Rare Diseases
Juliana Furtado Gets the Lower-link VPP Treatment - Mountain Bike Press Release - Vital MTB
Frontiers | Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
Multidrug-resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis – TB DIAH
Xpert MTB/RIF Ultra Is Highly Sensitive for the Diagnosis of Tuberculosis Lymphadenitis in a High-HIV Setting | Journal of Clinical Microbiology
Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center study | BMC Infectious Diseases | Full Text
Cepheid | Cepheid | TB Drug-Resistance Testing | Xpert MTB-XDR
Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study - eClinicalMedicine
Weakening Tuberculosis Bacteria's Defenses May Speed Treatment and Thwart Drug Resistance | Newsroom | Weill Cornell Medicine
Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia | PNAS
Early tuberculosis treatment monitoring by Xpert® MTB/RIF | European Respiratory Society
Can the GeneXpert MTB/XDR deliver on the promise of expanded, near-patient tuberculosis drug-susceptibility testing? - The Lancet Infectious Diseases
![PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4b2748c6b14c22d792915b1e9fc3db2be946ae59/3-Figure2-1.png "PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar")
PDF] Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis | Semantic Scholar
New agents for the treatment of drug-resistant Mycobacterium tuberculosis - ScienceDirect
Estimated viable Mtb in sputum during the first 56 days of treatment... | Download Scientific Diagram
Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study | PLOS ONE
A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis
